AA
ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
NASDAQ·Healthcare·Biotechnology
$23.00
-1.58%
Mkt Cap $2.20B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 24, 2026 | $44.40M | $49.49M | +11.46% | -$0.83 | -$0.65 | +21.69% | — | — |
| Q3 2025 Aug 20, 2025 | — | $32.55M | — | — | -$0.96 | — | — | — |
| Q1 2025 Mar 27, 2025 | — | $21.49M | — | $0.02 | -$1.00 | -6134.62% | — | — |
| Q3 2024 Aug 22, 2024 | — | $115.41M | — | — | $0.31 | — | — | — |
| Q2 2024 Jun 30, 2024 | — | $113.36M | — | — | $0.30 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | $11.19M | — | — | -$1.02 | — | — | — |
| Q3 2023 Aug 21, 2023 | — | $19.57M | — | — | -$0.81 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | $19.70M | — | — | -$3.15 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | $15.31M | — | — | -$3.91 | — | — | — |
| Q3 2022 Aug 26, 2022 | — | $13.84M | — | — | -$0.89 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | $15.65M | — | — | -$4.00 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | $339.77K | — | — | -$3.86 | — | — | — |
| Q3 2021 Aug 24, 2021 | — | $2.00M | — | — | -$0.94 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $334.58K | — | — | -$3.80 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | $953.61K | — | — | -$3.85 | — | — | — |
| Q3 2020 Aug 18, 2020 | — | $378.20K | — | — | -$0.89 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $881.64K | — | — | -$3.56 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | $1.05M | — | — | -$8.13 | — | — | — |
| Q2 2019 Jun 30, 2019 | — | $1.06M | — | — | -$8.15 | — | — | — |
| Q4 2018 Dec 31, 2018 | — | $1.02M | — | — | -$4.05 | — | — | — |